There are always, of course, risks with anything you do. The question is always: What’s the balance between potential benefits and potential downsides? We think a lot of attention needs to be paid to minimizing the downsides. There has been, at this point, I would say eight years of effort has gone into this particular question in working on and thinking about the rules just relating to patient data.
Will Obama’s science policy accomplishments survive? A Q&A with outgoing science adviser John Holdren
In the eight years that John P. Holdren has been White House science adviser—longer than anyone else has held the job—the U.S. signed a climate accord 20 years in the making, began regulating carbon dioxide as a pollutant and embarked on an ambitious research effort to understand how the human brain works.
Will these and other accomplishments survive the administration of Donald J. Trump, who will become the 45th president of the United States on January 20?
To find out, Holdren was interviewed at the White House on December 14. As director of the White House Office of Science and Technology Policy (OSTP), Holdren has been involved in just about every major decision the Obama administration has made regarding science and energy policy. Although he would not speculate on what the incoming Trump…
View original post 3,575 more words